Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Christopher J Kemp

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7238-8452; OpenAlex author ID A5112265164; NIH RePORTER profile ID 1894034. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
3
Labs led
1
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 3 grants

Papers 1

  1. Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL. Last author DOI 10.1158/0008-5472.can-21-4222↗

Grants 3

  1. Research Recovery Grant: Christopher Kemp (patient-derived tumor models for functional precision oncology) AWARD pancan:2026-christopher-kemp-phd-research-recovery-grant-christopher-kemp
  2. Ex vivo drug testing with patient derived tumor cells for translational research. R56CA309037↗
  3. A Patient-Centric Approach to Advance Functional Precision Oncology U01CA282109↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Venu Gopal Pillarisetty · 1 shared grant, 2026 · strength 1.26
  2. Russell D. Moser · 1 shared paper, 2022 · strength 0.13
  3. Calvin Jay Kuo · 1 shared paper, 2022 · strength 0.13
  4. Rosalie C. Sears · 1 shared paper, 2022 · strength 0.13
  5. Haiyong Han · 1 shared paper, 2022 · strength 0.13
  6. Andrew Victor Biankin · 1 shared paper, 2022 · strength 0.13
  7. Daniel D. Von Hoff · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.